
Why 30 Years of Trial Innovation Keeps Hitting the Same Wall
Episode 37
Scott Schliebner on DCTs, Patient-Centric Trials & 30 Years of Pharma Innovation | Pharma Prescribed Scott Schliebner — founder of Ascent Biostrategies and veteran of nearly 30 years across biotech, CROs and nonprofit life sciences — joins Adam Walker for a candid, longitudinal view of how drug development actually evolves. And how often it refuses to. From being one of the first to transition a clinical team from paper CRFs to electronic data capture, to building DCT infrastructure at PRA Health Sciences before COVID made it suddenly essential, Scott has watched innovation after innovation hit the wall of a deeply conservative industry. His verdict? Patching on technology doesn't work. What does is putting patients in the room before the protocol is written.
Publisher
Adam Walker’s Pharma Prescribed Podcast
Link
pharmaprescribed.podbean.com/e/pharma-prescribed-with-scott-schliebner-healthcares-unseen-heroes-the-technological-shift/
Published
March 13, 2026
Duration
44 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Adam Walker
Adam Walker’s Pharma Prescribed Podcast
@adamwalkerspharmaprescribedp
#years #trialinnovationkeeps #wall #lifesciences #management
